Literature DB >> 9216218

[Vitamin K deficiency syndrome caused by antituberculous agents].

F Ishii1, B Iizuka, T Nakanishi, K Nagasako, N Hayashi.   

Abstract

Vitamin K deficiency caused by antituberculous agents was examined in clinical patients and in experimental rats. When antituberculous agents given to the patients who had only total elental diet because of small intestinal dysfunction, a marked increase in plasma PIVKA-II and a decrease in thrombo-test value were observed. These changes were quickly normalized by administration of vitamin K, despite of succeeding or stopping of antituberculous agents. In rat experiments, effects of four agents (ethambutol, isoniazid, paraaminosalicylate, and rifampicin) on prothrombin time were studied. Among these agents, only rifampicin prolonged prothrombin time. This prolongation depended on drug doses and duration of administration. In addition to this hypoprothrombinemia, an increase in plasma PIVKA-II was also observed, and these changes were normalized within 24 hours of vitamin K administration. These data suggest that rifampicin inhibits vitamin K epoxide reductase interfering re-use of vitamin K and caused vitamin K deficiency in patients with total elental diet.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9216218

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN: 0446-6586


  3 in total

1.  Severe coagulopathy caused by rifampicin in patients with primary sclerosing cholangitis and refractory pruritus.

Authors:  Fotios Sampaziotis; William J H Griffiths
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

2.  Does endocarditis require routine coagulation screening?

Authors:  Mohammad Alkhalil; Stephen Tate
Journal:  BMJ Case Rep       Date:  2010-10-21

3.  Deranged Haemostasis: Rifampin-Induced Coagulopathy.

Authors:  Raghu Tiperneni; Farhan Khalid; Harshil Fichadiya; Ahmad Al-Alwan; Garuav Mohan; Farah Heis
Journal:  Eur J Case Rep Intern Med       Date:  2022-05-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.